SCHEMBL6374526

SCHEMBL6374526

C=C(C#N)C(=O)Nc1nc(C)cs1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.53
▸ RAB9A P51151 12/20 0.50
▸ NPC1 O15118 10/20 0.50
▸ POLB P06746 3/20 0.50
▸ HPGD P15428 3/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ KDM4E B2RXH2 2/20 0.46
▸ GAA P10253 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ TP53 P04637 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ RCE1 Q9Y256 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ PKM P14618 1/20 0.45
▸ CNR2 P34972 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8809685 0.79 RAB9A (0.50) MAPTRAB9ANPC1POLBHPGD
SCHEMBL9080024 0.79 RAB9A (0.50) MAPTRAB9ANPC1POLBHPGD
SCHEMBL9345674 0.79 MAPT (0.50) MAPTRAB9ANPC1POLBHPGD
SCHEMBL9345666 0.79 MAPT (0.50) MAPTRAB9ANPC1POLBHPGD
SCHEMBL11225467 0.77 MAPT (0.62) MAPTRAB9ANPC1POLBHPGD
SCHEMBL9463368 0.76 MAPT (0.47) MAPTRAB9ANPC1POLBHPGD
SCHEMBL5630056 0.75 MAPT (0.64) MAPTRAB9ANPC1POLBHPGD
SCHEMBL1691061 0.75 MAPT (0.68) MAPTRAB9ANPC1POLBHPGD
SCHEMBL10816647 0.75 RAB9A (0.71) MAPTRAB9ANPC1POLBHPGD
SCHEMBL11225869 0.74 MAPT (0.58) MAPTRAB9ANPC1POLBHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005072731-A1 3-PHENYL-N- ((1, 3, 4) THIADIAZOL-2-YL) -ACRYLAMIDE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF ESTROGEN-RELATED RECEPTORS FOR THE TREATMENT OF E.G. CANCER, RHEUMATOID ARTHRITIS OR NEUROLOGICAL DISORDERS X-CEPTOR THERAPEUTICS, INC. (US) 2005-08-11 — — WO disclosed
Send feedback